IL17A and colorectal carcinoma: Furthermore, indole-3-lactic acid (ILA), a metabolite derived from L. reutii upon gut enrichment, targets RORγt to inhibit Th17 cell differentiation and downregulate the IL-17 signaling pathway, thereby suppressing CRC development (186).